Skip to main content
. 2016 Jun 24;95:1435–1455. doi: 10.1007/s00277-016-2711-1

Table 4.

Secondary prophylaxis after toxoplasmosis disease

Intention Intervention SoR QoE Comments Ref
To prevent relapse of CNS toxoplasmosis Pyrimethamine (25 mg/day)a + sulfadiazine (orally, 30 mg/kg/d) A IIt Minimum duration for 3 months, many cases longer [204, 206]
Pyrimethamine (25 mg/d)a + clindamycin (intravenously, 1200 mg/d) B IIt [255257]
Atovaquone 750 mg qid B IIt In patients intolerant to conventional toxoplasmic encephalitis therapies [206]

aShould be combined with folinic acid

HHS Vulnerability Disclosure